Ultimately, the project could provide a tool for clinical research, because it could explain why cells sometimes react to medicines in unexpected ways.
A chemical such as a drug could function very well inside a cell most of the time, and then suddenly not work well at all, as if a switch had been flipped. For researchers who are trying to develop new biochemical agents, this means that results can vary widely from experiment to experiment.
Martin Feinberg and his colleagues wanted to know why.
Through computer simulations, they discovered that the answer -- mathematically, at least -- could come down to the rate at which chemicals enter a cell. The results of their simulations appear in a recent issue of the Proceedings of the National Academy of Sciences (PNAS).
Feinberg, the Richard M. Morrow Professor of chemical engineering and professor of mathematics at Ohio State, and Gheorghe Craciun, formerly of Ohio State's Mathematical Biosciences Institute, created visualizations of chemical reactions called species-reaction graphs ("species" are the different chemicals in a reaction). The graphs are maps of a sort, where lines and curves connect chemicals like roads connect destinations. Craciun is now an assistant professor of mathematics and biomolecular chemistry at the University of Wisconsin.
Based on the number of connections and how they overlap, Feinberg and Craciun can tell with a glance whether a reaction is predictable, or whether it might be what they call "quirky" -- prone to the switching behavior that occasionally produces strange results. They created a theorem that lays out mathematical rules that researchers can use to make the same judgment.
As it turns out, many of the graphs that describe biological reactions are quirky.
"Some of the graphs that come from classical biological reactions -- even simple ones -- indicate that these reactions might behave in very quirky ways," Feinberg said.
"This behavior may be essential to biology itself."
To test the theorem, he and his colleagues simulated a very simple chemical system on a computer: the behavior of a simplified biological cell containing an enzyme, DHFR (dihydrofolate reductase). DHFR is important in cell division because it helps provide an essential building block of DNA.
In fact, a classical chemotherapy agent, methotrexate, is used to thwart the operation of DHFR so that the out-of-control cell proliferation characteristic of cancer cannot take place.
Student Yangzhong Tang created the simulation software as part of her doctoral work. She described it as a simple computational tool which shows how rapidly DHFR converts reactants to products, depending on the rate at which reactants enter the cell. In particular, the software helps determine circumstances under which DHFR can operate in two very different conversion modes -- a rapid one and a slower one.
For the simulation, the researchers started with a low supply rate of reactants and then gradually increased the supply rate. At first, the DHFR converted reactants to products at 95 percent efficiency. Then, it abruptly dropped to 65 percent. When they decreased the flow rate, it just as abruptly returned to 95 percent.
"It was like a switch had been flipped, and the trigger was an increase or decrease of only 0.02 milliliters of reactant solution per minute," Feinberg said. "We were surprised to see that we could create such a dramatic switch just by changing the reactant supply rate a tiny amount.
"Keep in mind that this is in the absence of any methotrexate at all," he continued. "To understand what happens in the presence of the anti-cancer drug, one should be aware of the quirky phenomena that might be exhibited even when no methotrexate is present."
Seeing an unexpectedly low conversion efficiency of an enzyme during a laboratory experiment, scientists might erroneously conclude that there's something wrong with the enzyme or that the gene responsible for manufacturing the enzyme had gone awry. In fact, the real culprit might be a chemical switch, intrinsic to the mathematics, that is triggered by the reactant supply rate, Feinberg said.
The next step for the researchers is to try to observe this behavior in the laboratory. They are designing a plastic model cell with specialized filters so that they can carefully measure chemicals that enter and exit.
Several Ohio State professors have been assisting with development of that stage of the project, including Jeffrey Chalmers and S.T. Yang in the Department of Chemical and Biomolecular Engineering and Irina Artsimovitch of the Department of Microbiology.
Even after they do their laboratory experiments, Feinberg says he and his colleagues will be a long way from making any claims about what happens inside real biological cells. Their work implies that scientists should be cautious when interpreting the results of biochemical experiments, nothing more.
Still, he acknowledged that the theorem in the PNAS paper could ultimately help answer fundamental questions in chemistry, biochemistry, and evolution.
"Cells probably need a mechanism to switch readily between states in response to external signals," he ventured. "It could be an evolutionary advantage. So I think biology wants this to happen."
This work was funded by the National Science Foundation.
Martin Feinberg | EurekAlert!
Mass spectrometry sheds new light on thallium poisoning cold case
14.12.2018 | University of Maryland
Protein involved in nematode stress response identified
14.12.2018 | University of Illinois College of Agricultural, Consumer and Environmental Sciences
The more objects we make "smart," from watches to entire buildings, the greater the need for these devices to store and retrieve massive amounts of data quickly without consuming too much power.
Millions of new memory cells could be part of a computer chip and provide that speed and energy savings, thanks to the discovery of a previously unobserved...
What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.
The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...
A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.
Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...
Over the last decade, there has been much excitement about the discovery, recognised by the Nobel Prize in Physics only two years ago, that there are two types...
12.12.2018 | Event News
10.12.2018 | Event News
06.12.2018 | Event News
14.12.2018 | Power and Electrical Engineering
14.12.2018 | Physics and Astronomy
14.12.2018 | Physics and Astronomy